These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11455130)

  • 1. Analysis of alpha-2-macroglobulin-2 allele as a risk factor in Alzheimer's disease.
    Nicosia F; Alberici A; Benussi L; Gasparini L; Ghidoni R; Mazzoli F; Zanetti O; Frisoni GB; Geroldi C; Binetti G
    Dement Geriatr Cogn Disord; 2001; 12(5):305-8. PubMed ID: 11455130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of alpha-2-macroglobulin deletion polymorphism with sporadic Alzheimer's disease in Koreans.
    Jhoo JH; Kim KW; Lee DY; Lee KU; Lee JH; Kim SY; Youn JY; Youn JC; Woo JI
    J Neurol Sci; 2001 Feb; 184(1):21-5. PubMed ID: 11231028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [No evidence for genetic association between alpha-2 macroglobulin I1000V polymorphism and sporadic Alzheimer's disease in two independent Chinese populations].
    Sun Y; Shi J; Zhang S; Tang M; Liu X; Wang Y; Han H; Guo Y; Deng H; Zhao Z; Ma C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):174-9. PubMed ID: 15793779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-2-macroglobulin intronic polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease.
    Kovács T; Cairns NJ; Lantos PL
    Neurosci Lett; 1999 Sep; 273(1):61-83. PubMed ID: 10505652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression.
    Blennow K; Ricksten A; Prince JA; Brookes AJ; Emahazion T; Wasslavik C; Bogdanovic N; Andreasen N; Båtsman S; Marcusson J; Nägga K; Wallin A; Regland B; Olofsson H; Hesse C; Davidsson P; Minthon L; Jansson A; Palmqvist L; Rymo L
    J Neural Transm (Vienna); 2000; 107(8-9):1065-79. PubMed ID: 11041282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A deletion polymorphism of alpha(2)-macroglobulin gene and cerebral amyloid angiopathy.
    Yamada M; Sodeyama N; Itoh Y; Suematsu N; Otomo E; Matsushita M; Mizusawa H
    Stroke; 1999 Nov; 30(11):2277-9. PubMed ID: 10548657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha2 macroglobulin and the risk of Alzheimer's disease.
    Dodel RC; Du Y; Bales KR; Gao F; Eastwood B; Glazier B; Zimmer R; Cordell B; Hake A; Evans R; Gallagher-Thompson D; Thompson LW; Tinklenberg JR; Pfefferbaum A; Sullivan EV; Yesavage J; Alstiel L; Gasser T; Farlow MR; Murphy GM; Paul SM
    Neurology; 2000 Jan; 54(2):438-42. PubMed ID: 10668709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between alpha2-macroglobulin polymorphisms and Alzheimer's disease.
    Wang X; Luedecking EK; Minster RL; Ganguli M; DeKosky ST; Kamboh MI
    Hum Genet; 2001 Feb; 108(2):105-8. PubMed ID: 11281447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of polymorphisms in the LRP1 and A2M genes with Alzheimer's disease in the northern Chinese Han population.
    Yuan Q; Wang F; Xue S; Jia J
    J Clin Neurosci; 2013 Feb; 20(2):253-6. PubMed ID: 23186781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha2-macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease.
    Nacmias B; Tedde A; Cellini E; Forleo P; Orlacchio A; Guarnieri BM; Petruzzi C; D'Andrea F; Serio A; Sorbi S
    Neurosci Lett; 2001 Feb; 299(1-2):9-12. PubMed ID: 11166925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No genetic association between alpha-2 macroglobulin I1000V polymorphism and Japanese sporadic Alzheimer's disease.
    Shibata N; Ohnuma T; Takahashi T; Ohtsuka E; Ueki A; Nagao M; Arai H
    Neurosci Lett; 2000 Aug; 290(2):154-6. PubMed ID: 10936700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease.
    Mariani E; Seripa D; Ingegni T; Nocentini G; Mangialasche F; Ercolani S; Cherubini A; Metastasio A; Pilotto A; Senin U; Mecocci P
    J Neurol Sci; 2006 Sep; 247(2):187-91. PubMed ID: 16784755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-1 antichymotrypsin and alpha-2 macroglobulin gene polymorphisms are not associated with Korean late-onset Alzheimer's disease.
    Ki CS; Na DL; Kim HJ; Kim JW
    Neurosci Lett; 2001 Apr; 302(2-3):69-72. PubMed ID: 11290389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association of alpha-2 macroglobulin gene five-nucleotide deletion with AD in Taiwan Chinese.
    Hu CJ; Sung SM; Liu HC; Lee KY; Hsu WC; Wong WK; Lee CC; Tsai CH; Chang JG
    Neurology; 1999 Aug; 53(3):642-3. PubMed ID: 10449138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sample.
    Crawford F; Town T; Freeman M; Schinka J; Gold M; Duara R; Mullan M
    Neurosci Lett; 1999 Aug; 270(3):133-6. PubMed ID: 10462112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms.
    Zappia M; Manna I; Serra P; Cittadella R; Andreoli V; La Russa A; Annesi F; Spadafora P; Romeo N; Nicoletti G; Messina D; Gambardella A; Quattrone A
    Arch Neurol; 2004 Mar; 61(3):341-4. PubMed ID: 15023809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic association between alpha-2 macroglobulin and Japanese sporadic Alzheimer's disease.
    Shibata N; Ohnuma T; Takahashi T; Ohtsuka E; Ueki A; Arai H
    Neurosci Lett; 1999 Aug; 271(2):132-4. PubMed ID: 10477120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between an alpha(2) macroglobulin DNA polymorphism and late-onset Alzheimer's disease.
    Alvarez V; Alvarez R; Lahoz CH; Martínez C; Peña J; Guisasola LM; Salas-Puig J; Morís G; Uría D; Menes BB; Ribacoba R; Vidal JA; Sánchez JM; Coto E
    Biochem Biophys Res Commun; 1999 Oct; 264(1):48-50. PubMed ID: 10527839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic Study on the Impact of Rivastigmine Concerning Genetic Variants of A2M and IL-6 Genes on Iranian Alzheimer's Patients.
    Zamani M; Mohammadi M; Zamani H; Tavasoli A
    Mol Neurobiol; 2016 Sep; 53(7):4521-8. PubMed ID: 26289409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies.
    Singleton AB; Gibson AM; McKeith IG; Ballard CA; Perry RH; Ince PG; Edwardson JA; Morris CM
    Neuroreport; 1999 May; 10(7):1507-10. PubMed ID: 10380971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.